II
DYN icon

Inspire Investing’s Dyne Therapeutics DYN Stock Holding History

Inspire Investing’s Portfolio DYN Stock Details DYN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$169K Buy
+9,303
New +$160K 0.01% 888
2023
Q2 		– Sell
-39,722
Closed -$458K – 800
2023
Q1 		$458K Buy
+39,722
New +$516K 0.06% 253

Other funds holding DYN

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $722M AUM 73.61% 1-Year Est. Return

Inspire Investing's DYN Position: Q1 2026 in Review

Inspire Investing opened a new position in Dyne Therapeutics (DYN) in Q1 2026: 9,303 shares worth $169K. The stake represents 0.01% of the portfolio and ranks #888 among its holdings. This is a return to the name: Inspire Investing previously reported a position in DYN as recently as Q1 2023.

Inspire Investing first reported a position in DYN in Q1 2023 and has held it in 2 quarters since. The position peaked at $458K in Q1 2023. 227 funds tracked by Wall St. Rank hold DYN as of Q1 2026.

  • Inspire Investing held 9,303 shares of Dyne Therapeutics worth $169K as of Q1 2026.
  • Dyne Therapeutics was a new Inspire Investing position in Q1 2026.
  • Dyne Therapeutics made up 0.01% of Inspire Investing's portfolio in Q1 2026, its #888 holding.
  • Inspire Investing first reported a position in Dyne Therapeutics in Q1 2023 and has held it in 2 quarters since.
  • Inspire Investing's Dyne Therapeutics position peaked at $458K in Q1 2023.
  • 227 funds tracked by Wall St. Rank held Dyne Therapeutics as of Q1 2026.

Based on Inspire Investing's 13F filing for Q1 2026, filed 23 Apr 2026.